Your child may have RSV. RSV or respiratory syncytial virus is a common seasonal infection usually peaking in January. This condition is most noticeable in our young patients. Their airways are ...
Coughing, sneezing, wheezing? High fever and no sleep? Your child may have RSV. RSV or respiratory syncytial virus is a common seasonal infection usually peaking in January. This condition is most ...
We are so excited to announce the College has created the new Reproductive Health and Cardio-Obstetrics Member Section. Cardio-Obstetrics is a tremendous area of burgeoning growth in cardiology as it ...
The findings of the study were reported in the American Journal of Obstetrics and Gynecology. Respiratory syncytial virus (RSV) vaccine timing can influence how effectively antibodies are ...
There are now three shots for adults over the age of 60, with Pfizer's Abrysvo also approved to be given in the final weeks of pregnancy to help protect newborns. Bowden claims researchers are not ...
Zhu and his research team first analyzed the F proteins used in development of four existing RSV vaccines—the commercially available Arexvy, mResvia and Abrysvo, and an experimental vaccine that has ...
“Whilst GSK is unhappy with the High Court’s decision and plans to appeal it, it is unlikely that the verdict will change within the U.K. and thus Pfizer’s Abrysvo and GSK’s Arexvy will continue to be ...
Pfizer expects better non-COVID operational revenue growth in the upcoming quarters, driven by its products like Vyndaqel and Prevnar; launches like Abrysvo, Velsipity and Penbraya; and newly ...
Leader Electronics has announced TVN Live Production has deployed its solutions in its latest OB truck. The newest addition to TVN’s European fleet, the TVN-OB8, has been designed for UHD, HDR and ...
Zhu and his research team first analyzed the F proteins used in development of four existing RSV vaccines—the commercially available Arexvy, mResvia and Abrysvo, and an experimental vaccine that ...
GSK adds patent issued this week to infringement suit Abrysvo’s recent approval for ages 18-59 now in GSK crosshairs GSK Plc added allegations involving a newly issued patent to its 15-month-old ...